scispace - formally typeset
Search or ask a question
Author

Guangli Yu

Bio: Guangli Yu is an academic researcher from Ocean University of China. The author has contributed to research in topics: Gut flora & Fucoidan. The author has an hindex of 37, co-authored 147 publications receiving 4421 citations.


Papers
More filters
Journal ArticleDOI
TL;DR: The present paper will provide an update on the structural chemistry of the major sulfated polysaccharides synthesized by seaweeds including the galactans, ulvans, and fucans and the recent findings on the anticoagulant/antithrombotic, antiviral, immuno-inflammatory, antilipidemic and antioxidant activities of sulfated Polysaccharide and their potential for therapeutic application.
Abstract: Sulfated polysaccharides and their lower molecular weight oligosaccharide derivatives from marine macroalgae have been shown to possess a variety of biological activities. The present paper will review the recent progress in research on the structural chemistry and the bioactivities of these marine algal biomaterials. In particular, it will provide an update on the structural chemistry of the major sulfated polysaccharides synthesized by seaweeds including the galactans (e.g., agarans and carrageenans), ulvans, and fucans. It will then review the recent findings on the anticoagulant/antithrombotic, antiviral, immuno-inflammatory, antilipidemic and antioxidant activities of sulfated polysaccharides and their potential for therapeutic application.

834 citations

Journal ArticleDOI
Qingsen Shang1, Xindi Shan1, Chao Cai1, Jiejie Hao1, Guoyun Li1, Guangli Yu1 
TL;DR: Modulations of gut microbiota by different fucoidans were studied and it was found that at the expense of opportunistic pathogenic bacteria such as Peptococcus, the abundance of beneficial bacteria was significantly increased in response to fucoidan treatment.
Abstract: Recently, fucoidan has been proposed as a potential prebiotic agent for functional food and pharmaceutical development. However, while previous studies illustrated favorable modulations of gut microbiota by fucoidan, changes in the overall microbial structure remain elusive. In the present study, modulations of gut microbiota by different fucoidans were studied using high throughput sequencing and bioinformatics analysis. We found that at the expense of opportunistic pathogenic bacteria such as Peptococcus, the abundance of beneficial bacteria including Lactobacillus and Ruminococcaceae was significantly increased in response to fucoidan treatment. Besides, by maintaining a more balanced composition of gut microbiota, dietary fucoidan also significantly reduced the antigen load and the inflammatory response in the host as evidenced by the decreased serum lipopolysaccharide-binding protein levels. Collectively, our results indicate that fucoidan can be used as a gut microbiota modulator for health promotion and treatment of intestinal dysbiosis.

237 citations

Journal ArticleDOI
TL;DR: Anticoagulant activities of the four fCSs can be attributed to the difference in sulfation pattern of the fucose branch of the chondroitin sulfate, and 2,4- O -disulfation is important for anticoagULant activity.

230 citations

Journal ArticleDOI
TL;DR: A novel application of fucoidan as an anti-MetS functional food is illustrated and new insight is sheds new insight into the mechanism by which unabsorbed polysaccharide exerts a system therapeutic effect.

189 citations

Journal ArticleDOI
Qingsen Shang1, Hao Jiang1, Chao Cai1, Jiejie Hao1, Guoyun Li1, Guangli Yu1 
TL;DR: Up-to-date findings on how marine polysaccharides are metabolized by gut microbiota and what effects these poly Saccharides have on intestinal ecology are described and summarized.

150 citations


Cited by
More filters
Journal ArticleDOI
TL;DR: Short chain fatty acids have distinct physiological effects: they contribute to shaping the gut environment, influence the physiology of the colon, they can be used as energy sources by host cells and the intestinal microbiota and they also participate in different host-signaling mechanisms.
Abstract: The colon is inhabited by a dense population of microorganisms, the so-called “gut microbiota”, able to ferment carbohydrates and proteins that escape absorption in the small intestine during digestion. This microbiota produces a wide range of metabolites, including short chain fatty acids (SCFA). These compounds are absorbed in the large bowel and are defined as 1-6 carbon volatile fatty acids which can present straight or branched-chain conformation. Their production is influenced by the pattern of food intake and diet-mediated changes in the gut microbiota. SCFA have distinct physiological effects: they contribute to shaping the gut environment, influence the physiology of the colon, they can be used as energy sources by host cells and the intestinal microbiota and they also participate in different host-signalling mechanisms. We summarize the current knowledge about the production of SCFA, including bacterial cross-feedings interactions, and the biological properties of these metabolites with impact on the human health

1,344 citations

Journal ArticleDOI
TL;DR: Preclinical and clinical experience gained during the development of polymeric excipients, biomedical polymers and polymer therapeutics shows that judicious development of dendrimer chemistry for each specific application will ensure development of safe and important materials for biomedical and pharmaceutical use.

1,083 citations

Journal ArticleDOI
TL;DR: This review describes important aspects of carrageenans related to their industrial/therapeutic applications, physicochemical properties and structural analysis and indicates that these polysaccharides may offer some protection against HIV infection.

986 citations

Journal ArticleDOI
TL;DR: This work highlights this rapidly advancing area of algal science with a particular focus on the key research required to assess better the health benefits of an alga or algal product.
Abstract: Global demand for macroalgal and microalgal foods is growing, and algae are increasingly being consumed for functional benefits beyond the traditional considerations of nutrition and health. There is substantial evidence for the health benefits of algal-derived food products, but there remain considerable challenges in quantifying these benefits, as well as possible adverse effects. First, there is a limited understanding of nutritional composition across algal species, geographical regions, and seasons, all of which can substantially affect their dietary value. The second issue is quantifying which fractions of algal foods are bioavailable to humans, and which factors influence how food constituents are released, ranging from food preparation through genetic differentiation in the gut microbiome. Third is understanding how algal nutritional and functional constituents interact in human metabolism. Superimposed considerations are the effects of harvesting, storage, and food processing techniques that can dramatically influence the potential nutritive value of algal-derived foods. We highlight this rapidly advancing area of algal science with a particular focus on the key research required to assess better the health benefits of an alga or algal product. There are rich opportunities for phycologists in this emerging field, requiring exciting new experimental and collaborative approaches.

933 citations

Journal ArticleDOI
TL;DR: The present paper will provide an update on the structural chemistry of the major sulfated polysaccharides synthesized by seaweeds including the galactans, ulvans, and fucans and the recent findings on the anticoagulant/antithrombotic, antiviral, immuno-inflammatory, antilipidemic and antioxidant activities of sulfated Polysaccharide and their potential for therapeutic application.
Abstract: Sulfated polysaccharides and their lower molecular weight oligosaccharide derivatives from marine macroalgae have been shown to possess a variety of biological activities. The present paper will review the recent progress in research on the structural chemistry and the bioactivities of these marine algal biomaterials. In particular, it will provide an update on the structural chemistry of the major sulfated polysaccharides synthesized by seaweeds including the galactans (e.g., agarans and carrageenans), ulvans, and fucans. It will then review the recent findings on the anticoagulant/antithrombotic, antiviral, immuno-inflammatory, antilipidemic and antioxidant activities of sulfated polysaccharides and their potential for therapeutic application.

834 citations